Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
01/2013
01/10/2013US20130012492 Fused heterocyclic compounds as ion channel modulators
01/10/2013US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use
01/10/2013US20130009142 Charge transport compositions and electronic devices made with such compositions
01/10/2013CA2840883A1 Substituted azaheterocycles for the treatment of cancer
01/10/2013CA2840095A1 Compounds for the treatment of hiv
01/10/2013CA2839937A1 Processes and intermediates for producing azaindoles
01/10/2013CA2838223A1 Fused benzoxazepinones as ion channel modulators
01/09/2013EP2543668A1 Pyridopyrazindione derivative and use thereof as an antiulcer agent
01/09/2013EP2543667A1 2-aminopyridine analogs as glucokinase activators
01/09/2013EP2543375A1 Pyrrolo-pyrimidine analogues as inhibitors of bruton's tyrosine kinase
01/09/2013EP2542552A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
01/09/2013EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase
01/09/2013EP2542528A1 Heterocyclic amides as rock inhibitors
01/09/2013EP2542086A1 Compounds and therapeutic uses thereof
01/09/2013CN102869662A Organic electroluminescence devices
01/09/2013CN102869661A Anti-infective compounds
01/09/2013CN102869657A Analogues for the treatment or prevention of flavivirus infections
01/09/2013CN102869359A Imidazopyridine compounds, compositions and methods of use
01/09/2013CN102863447A Imidazole chiral organic small molecular compound with dual-loop structure and synthetic method thereof
01/09/2013CN102863443A Method for preparing high-purity high-yield oxysophoridine
01/09/2013CN102863442A Preparation method of high-purity rhazimine
01/09/2013CN102863441A Clic central nervous system active agents
01/09/2013CN102863440A Crystallographic form of salt of dipeptidyl peptidase-IV inhibitor
01/09/2013CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor
01/09/2013CN102863387A Novel synthetic method for imidazole onium salts
01/09/2013CN102250092B Preparation process of alkaloid tabersonine
01/09/2013CN101875658B Preparation method of 3-carbonyl-2,8-diazepine helix[4.5]decane-8-carboxylic acid tert-butyl ester
01/09/2013CN101730696B 3-aza-bicyclo[3.3.0]octane compounds
01/09/2013CN101711243B 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
01/09/2013CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof
01/08/2013US8350041 Tricyclic δ-opioid modulators
01/08/2013US8349866 High penetration prodrug compositions of 1H-imidazo[4,5-C]quinolin-4-amines and 1H-imidazo[4,5-C]quinolin-4-amine-related compounds
01/08/2013US8349865 Inhibitors of janus kinases
01/08/2013US8349844 Substituted pyrazolo [1,5-A] pyrimidines as metabotropic glutamate antagonists
01/08/2013US8349830 Aryl aminopyridine PDE10 inhibitors
01/08/2013US8349827 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
01/08/2013US8349824 Triazolopyridine compounds
01/08/2013CA2653941C Substituted amino purine derivatives and uses thereof
01/08/2013CA2569125C Pyrrolopyridine derivatives and their use as crth2 antagonists
01/08/2013CA2566155C 1-aza-bicyclo[3.3.1]nonanes
01/08/2013CA2527420C Compounds, methods and pharmaceutical compositions for inhibiting parp
01/03/2013WO2013003383A1 Bridged bicyclic compounds for the treatment of bacterial infections
01/03/2013WO2013003315A2 Methods for preparing isoquinolines
01/03/2013WO2013002051A1 Organic electroluminescent element
01/03/2013WO2013001445A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
01/03/2013WO2013001088A1 Direct synthesis of 18f-fluoromethoxy compounds for pet imaging and the provision of new precursors for direct radiosynthesis of protected derivatives of o-([18f]fluoromethyl) tyrosine
01/03/2013WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a
01/03/2013WO2012088491A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
01/03/2013US20130005978 Process for the manufacture of pharmaceutically active compounds
01/03/2013US20130005976 Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV
01/03/2013US20130005963 Organic photoelectric conversion material and organic thin-film photoelectric conversion device
01/03/2013US20130005760 Heterocyclic compound having azole group
01/03/2013US20130005751 Heterobicyclic carboxamides as inhibitors for kinases
01/03/2013US20130005750 Heterobicyclic carboxamides as inhibitors for kinases
01/03/2013US20130005743 New positive allosteric modulators of nicotinic acetylcholine receptor
01/03/2013US20130005725 Chemical compounds
01/03/2013US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof
01/03/2013US20130005721 Indolizine inhibitors of 5-lipoxygenase
01/03/2013US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a
01/03/2013US20130005675 Quinolone compound and pharmaceutical composition
01/03/2013US20130005576 Substituted Pyridazines Having Herbicidal Action
01/03/2013US20130004458 Small Molecule Inhibitors of Retroviral Assembly and Maturation
01/03/2013US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
01/03/2013US20130001524 Heterocyclic compound and organic light-emitting device comprising the same
01/03/2013CA2840768A1 Direct synthesis of 18f-fluoromethoxy compounds for pet imaging and new precursors for direct radiosynthesis of protected derivatives of o-([18f]fluoromethyl) tyrosine
01/03/2013CA2840315A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
01/03/2013CA2840060A1 Bridged bicyclic compounds for the treatment of bacterial infections
01/03/2013CA2839655A1 Novel inhibitor compounds of phosphodiesterase type 10a
01/03/2013CA2838321A1 Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system diseases
01/02/2013EP2540727A1 Sulfamoylating reagent
01/02/2013EP2540723A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
01/02/2013EP2540722A1 Novel anxiolytic compounds
01/02/2013EP2540721A1 Ghrelin receptor agonist for treatment of dyscrasia
01/02/2013EP2540720A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
01/02/2013EP2540710A1 New precursors for direct radiosynthesis of protected derivatives of O-([18F]Fluoromethyl) tyrosine
01/02/2013EP2539339A2 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
01/02/2013EP2539338A1 Novel microbicides
01/02/2013EP2539337A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
01/02/2013EP2539336A2 Hetarylaminonaphthyridines
01/02/2013EP2539322A1 Inhibitors of beta-secretase
01/02/2013EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
01/02/2013CN102858772A Imidazo[1,2-a]pyridine derivative
01/02/2013CN102858771A 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as HIV integrase inhibitor
01/02/2013CN102858770A Bicyclic Compounds And Their Uses As Dual C-src / Jak Inhibitors
01/02/2013CN102858769A Pyrazolopyridine kinase inhibitors
01/02/2013CN102858768A Substituted triazolopyridines
01/02/2013CN102858754A RAF inhibitor compounds and methods of use thereof
01/02/2013CN102858746A Novel 3,3-dimethyl tetrahydroquinoline derivatives
01/02/2013CN102850352A Preparation method high-purity high-yield oxysophocarpine
01/02/2013CN102850351A Method for extraction of sparteine from Thermopsis lanceolata
01/02/2013CN102850350A Method for extraction of evodiamine by using subcritical fluid
01/02/2013CN102850349A Fused, tricyclic sulfonamide inhibitors of gamma secretase
01/02/2013CN102850348A Pentaphenyl quinacridone derivative and application of pentaphenyl quinacridone derivative in aspect of fluorescent material
01/02/2013CN102850347A Resolution method for pyrazole derivative or salt thereof
01/02/2013CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders
01/02/2013CN102850329A Triazinyl derivative compound and its application in OLED (organic light emission diode)
01/02/2013CN102850322A Heterocyclic compound, organic light-emitting device, and panel display device
01/02/2013CN102180873B Functional ionic liquid and preparation method thereof
01/02/2013CN102101868B 1,1'-bicarboline N,N'-dioxocompound and synthesis and application thereof
01/02/2013CN101965347B Pyrazolopyridines as kinase inhibitors
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 646